You are here » Home » Companies » Company Overview » Gennex Laboratories Ltd

Gennex Laboratories Ltd.

BSE: 531739	Sector: Health care
NSE: N.A.	ISIN Code: INE509C01026

BSE 12:49 | 28 Sep

6.60

0
(0.00%)

OPEN

6.69

HIGH

6.69

LOW

6.52

NSE 05:30 | 01 Jan

Gennex Laboratories Ltd

Add to Watchlist | Add to Portfolio

OPEN	6.69
PREVIOUS CLOSE	6.60
VOLUME	51747
52-Week high	12.26
52-Week low	5.75
P/E	22.76
Mkt Cap.(Rs cr)	83
Buy Price	6.58
Buy Qty	9030.00
Sell Price	6.60
Sell Qty	3669.00

OPEN	6.69
CLOSE	6.60
VOLUME	51747
52-Week high	12.26
52-Week low	5.75
P/E	22.76
Mkt Cap.(Rs cr)	83
Buy Price	6.58
Buy Qty	9030.00
Sell Price	6.60
Sell Qty	3669.00

Gennex Laboratories Ltd. (GENNEXLAB) - News Sector

Torrent Pharma to acquire Curatio Healthcare for Rs 2,000 cr; stock down 6%

9.43 am | 28 Sep 2022 | Business Standard

ICICI Securities is positive on Torrent's ability of faster integration and turnaround of acquired assets in the domestic space
Torrent Pharma acquires cosmetic derma player Curatio for Rs 2,000 cr

10.55 pm | 27 Sep 2022 | Business Standard

First major acquisition by Aman Mehta after taking charge at Torrent Pharma in August
Stay committed to patients in India and Fortis Healthcare, says IHH

9.21 pm | 27 Sep 2022 | Business Standard

Taking legal advice on next steps to pursue open offer for 26% stake in Fortis
HUL, Asian Paints: 5 stocks withstood recent sell-off; Will they rise more?

12.38 pm | 27 Sep 2022 | Business Standard

Among individual stocks, Asian Paints, EIH and Alkem Laboratories can rally up to 18 per cent each. Hindustan Unilever and Metro Brands too are poised...
Aurobindo slips 6% in a week after arm receives EIR from USFDA

10.58 am | 27 Sep 2022 | Business Standard

In the past six months, Aurobindo has underperformed the market by falling 31 per cent, as compared to a marginal 0.07 per cent decline in the S&P BSE...
Here's why Mehul Kothari recommends buying Metropolis, Thyrocare Tech

7.35 am | 27 Sep 2022 | Business Standard

According to the technical analyst from Anand Rathi, Metropolis Healthcare can rally to Rs 1,800, while Thyrocare Technologies can rise up to Rs 740.
Here's why Mehul Kothari recommends buying Metropolis, Thyrocare Tech

7.35 am | 27 Sep 2022 | Business Standard

According to the technical analyst from Anand Rathi, Metropolis Healthcare can rally to Rs 1,800, while Thyrocare Technologies can rise up to Rs 740.
Centre looking to phase out codeine-based cough syrups, select FDCs

12.09 am | 27 Sep 2022 | Business Standard

The industry is divided on the issue of phasing out codeine-based cough syrups, which are used by many as intoxicants
Piramal Enterprises slips 9% to hit 52-week low; stock slumps 11% in 2 days

12.05 pm | 26 Sep 2022 | Business Standard

In the past two days, the stock slipped 11 per cent after the RBI directed M&M Financial Services to immediately cease any recovery or repossession ac...
Indian generic formulation-makers level of capex declining: Candle Partners

12.39 pm | 25 Sep 2022 | Business Standard

Candle Partners study shows that from the peak of 30% of gross block in FY16, the capex is down to 9-10% of gross block
Analysts cautious on Fortis Healthcare post SC verdict; stock tanks 18%

6.33 pm | 23 Sep 2022 | Business Standard

Apart from a forensic audit in the Fortis-IHH deal, the Supreme Court on Thursday also announced a jail term of six months for Malvinder Singh and Shi...
Stocks to Watch: Tata Steel, Fortis, Hero MotoCorp, Bombay Dyeing, McLeod

8.04 am | 23 Sep 2022 | Business Standard

Stocks to Watch Today: UCO Bank became the first bank to get RBI nod for Rupee trade settlement a/c with Russia; The Central Bank warns M&M Finance ag...
Top headlines: Fortis shares tank on SC verdict; Rupee hits new low

4.46 pm | 22 Sep 2022 | Business Standard

The rupee closed at a record low of 80.86 to the dollar, down from 79.9750 in the previous session
Gautam Adani earned Rs 1,612 crore a day in 2021: Hurun India

2.58 pm | 21 Sep 2022 | Business Standard

Adani was far ahead of Reliance Industries' chairman Mukesh Ambani (Mukesh Ambani & family), whose wealth rose 11 per cent in the last one year
M&M, Central Bank, Solara: Trading strategies for buzzing stocks of the day

12.04 pm | 21 Sep 2022 | Business Standard

These five stocks were are trading with strong gains on Wednesday despite the nervouss undertone in the broader market ahead of US Fed rate decision l...
M&M, Central Bank, Solara: Trading strategies for buzzing stocks of the day

12.04 pm | 21 Sep 2022 | Business Standard

These five stocks were are trading with strong gains on Wednesday despite the nervouss undertone in the broader market ahead of US Fed rate decision l...
Stocks to Watch: Central Bank, ITI, M&M, Yes Bank, SpiceJet, PEL, GPT Infra

7.26 am | 21 Sep 2022 | Business Standard

Stocks to Watch Today: Central Bank of India has removed from the RBI's PCA framework after 5 years; SpiceJet places 80 pilots on leave without pay fo...
Growth forecast in US market set to drive gains for Cipla stock

11.05 pm | 20 Sep 2022 | Business Standard

Street remains bullish on India prospects, regulatory headwinds for Goa site continue
India's first off-the-shelf cell therapy treatment for knee osteoarthritis

8.15 pm | 18 Sep 2022 | Business Standard

One injection will cost Rs 1.25 lakh with effects lasting for two years or more
Derivatives analyst Nandish Shah recommends Bull Spread on Granules India

7.52 am | 16 Sep 2022 | Business Standard

The analyst from HDFC Securities recommends buying Granules India 320 Call and simultaneously selling 340 Call of the September series.